tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (CH:NWRN)
:NWRN
Switzerland Market
Advertisement

Newron Pharmaceuticals SpA (NWRN) Ratios

Compare
0 Followers

Newron Pharmaceuticals SpA Ratios

CH:NWRN's free cash flow for Q4 2024 was €1.00. For the 2024 fiscal year, CH:NWRN's free cash flow was decreased by € and operating cash flow was €0.70. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.60 0.68 5.65 10.79 5.50
Quick Ratio
2.60 0.68 5.65 10.79 5.50
Cash Ratio
0.29 0.22 2.66 6.85 1.92
Solvency Ratio
0.26 -0.29 -0.34 -0.31 -0.61
Operating Cash Flow Ratio
-0.75 -0.35 -2.20 -3.13 -2.26
Short-Term Operating Cash Flow Coverage
-1.31 -0.46 0.00 0.00 0.00
Net Current Asset Value
€ -1.35M€ -36.12M€ -22.73M€ -7.95M€ 3.92M
Leverage Ratios
Debt-to-Assets Ratio
0.79 1.87 1.23 0.85 0.51
Debt-to-Equity Ratio
34.62 -1.62 -3.25 13.87 1.53
Debt-to-Capital Ratio
0.97 2.62 1.44 0.93 0.60
Long-Term Debt-to-Capital Ratio
0.96 -6.20 1.45 0.93 0.60
Financial Leverage Ratio
43.83 -0.86 -2.65 16.25 2.97
Debt Service Coverage Ratio
1.15 -0.45 -3.38 -4.22 -8.65
Interest Coverage Ratio
6.01 -2.79 -3.37 -4.23 -8.07
Debt to Market Cap
0.27 0.51 1.62 1.53 0.72
Interest Debt Per Share
2.95 2.95 2.78 2.58 1.60
Net Debt to EBITDA
1.68 -3.56 -2.42 -1.47 -0.73
Profitability Margins
Gross Profit Margin
100.00%100.00%100.00%100.00%94.39%
EBIT Margin
50.10%-132.85%-221.94%-207.67%-330.52%
EBITDA Margin
50.47%-130.63%-218.62%-213.64%-342.22%
Operating Profit Margin
50.93%-128.40%-218.28%-214.46%-343.59%
Pretax Profit Margin
41.63%-178.87%-286.71%-258.31%-373.11%
Net Profit Margin
30.83%-179.13%-287.05%-258.61%-399.35%
Continuous Operations Profit Margin
30.83%-179.13%-287.05%-258.61%-399.35%
Net Income Per EBT
74.05%100.15%100.12%100.11%107.03%
EBT Per EBIT
81.74%139.31%131.35%120.45%108.59%
Return on Assets (ROA)
24.79%-62.72%-47.03%-29.52%-41.01%
Return on Equity (ROE)
-107.87%54.25%124.68%-479.59%-121.76%
Return on Capital Employed (ROCE)
64.78%380.03%-41.37%-26.39%-40.78%
Return on Invested Capital (ROIC)
35.92%-60.06%-55.14%-33.89%-60.66%
Return on Tangible Assets
24.79%-62.72%-47.03%-29.52%-41.02%
Earnings Yield
9.28%-17.06%-62.62%-53.50%-59.19%
Efficiency Ratios
Receivables Turnover
1.21 3.58 3.13 4.41 0.79
Payables Turnover
0.00 0.00 0.00 0.00 0.23
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
61.62 22.36 11.56 9.99 7.16
Asset Turnover
0.80 0.35 0.16 0.11 0.10
Working Capital Turnover Ratio
1.97 1.28 0.21 0.17 0.15
Cash Conversion Cycle
301.31 101.96 116.44 82.86 -1.12K
Days of Sales Outstanding
301.31 101.96 116.44 82.86 459.83
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 0.00 0.00 1.58K
Operating Cycle
301.31 101.96 116.44 82.86 459.83
Cash Flow Ratios
Operating Cash Flow Per Share
-0.95 -0.57 -0.62 -0.64 -0.87
Free Cash Flow Per Share
-0.95 -0.57 -0.62 -0.64 -0.88
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-1.35K -921.82 -616.22 -572.25 -458.47
Capital Expenditure Coverage Ratio
-1.35K -921.82 -616.22 -572.25 -458.47
Operating Cash Flow Coverage Ratio
-0.35 -0.21 -0.24 -0.27 -0.59
Operating Cash Flow to Sales Ratio
-0.34 -1.12 -1.82 -1.99 -2.96
Free Cash Flow Yield
-9.60%-10.67%-39.77%-41.16%-44.03%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.79 -5.86 -1.60 -1.87 -1.69
Price-to-Sales (P/S) Ratio
3.58 10.50 4.58 4.83 6.75
Price-to-Book (P/B) Ratio
117.22 -3.18 -1.99 8.96 2.06
Price-to-Free Cash Flow (P/FCF) Ratio
-10.43 -9.37 -2.51 -2.43 -2.27
Price-to-Operating Cash Flow Ratio
-9.70 -9.38 -2.52 -2.43 -2.28
Price-to-Earnings Growth (PEG) Ratio
0.06 0.82 -0.10 0.06 -0.38
Price-to-Fair Value
117.22 -3.18 -1.99 8.96 2.06
Enterprise Value Multiple
8.76 -11.59 -4.52 -3.73 -2.70
Enterprise Value
227.21M 137.18M 60.17M 45.92M 48.61M
EV to EBITDA
8.76 -11.59 -4.52 -3.73 -2.70
EV to Sales
4.42 15.15 9.87 7.97 9.24
EV to Free Cash Flow
-12.89 -13.51 -5.42 -4.00 -3.11
EV to Operating Cash Flow
-12.90 -13.53 -5.42 -4.01 -3.12
Tangible Book Value Per Share
0.08 -1.68 -0.79 0.17 0.97
Shareholders’ Equity Per Share
0.08 -1.68 -0.79 0.17 0.97
Tax and Other Ratios
Effective Tax Rate
0.26 >-0.01 >-0.01 >-0.01 -0.07
Revenue Per Share
2.77 0.51 0.34 0.32 0.29
Net Income Per Share
0.85 -0.91 -0.98 -0.84 -1.18
Tax Burden
0.74 1.00 1.00 1.00 1.07
Interest Burden
0.83 1.35 1.29 1.24 1.13
Research & Development to Revenue
0.27 1.45 1.98 1.87 3.11
SG&A to Revenue
0.14 0.44 1.17 1.26 1.53
Stock-Based Compensation to Revenue
<0.01 0.02 0.08 0.13 0.28
Income Quality
-0.82 0.63 0.63 0.77 0.74
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis